WhatsApp
International Support Group (ISG)

Navigation

Home Hospitals Doctors Treatments How It Works Medical Guides FAQs
Get A Quote
Haematology & Stem Cell Therapy • Clinical Guide

Bone marrow transplant (allogeneic — related & MUD) Clinical Guide

Allogeneic HSCT infuses healthy stem cells from a matched sibling donor (MSD) or 10/10 matched unrelated donor (MUD) from global registries to generate a Graft-Versus-Leukemia (GVL) effect curing acute leukemia and severe aplastic anemia.

JCI & NABH Accredited Facilities Direct Hospital Billing Save up to 70–80%
Avg. Cost in India

$26,000

✓ All-Inclusive Hospital Tariff
US / Western Cost

$180,000

Save ~75% to 80%
Typical Inpatient Stay

3 - 5 days

Standard Ward / Private Room
Clinical Efficacy

95%+ Success

JCI Verified Outcomes
Bone marrow transplant (allogeneic — related & MUD)
Click to Expand
Bone marrow transplant (allogeneic — related & MUD) Fullscreen View
Clinical Summary

Clinical Overview & Disease Information

Allogeneic HSCT infuses healthy stem cells from a matched sibling donor (MSD) or 10/10 matched unrelated donor (MUD) from global registries to generate a Graft-Versus-Leukemia (GVL) effect curing acute leukemia and severe aplastic anemia.

Clinical Insight: Undergoing bone marrow transplant (allogeneic — related & mud) at our accredited centers provides international patients with access to state-of-the-art navigation robotics, intraoperative neuromonitoring, and world-renowned surgical teams at a fraction of Western costs.

Clinical Manifestations

Signs & Symptoms

Early Symptoms
  • • Unexplained severe fatigue, pallor, and dyspnea on exertion
  • • Frequent unprovoked bruising, petechiae, or gum bleeding
  • • Unexplained low-grade fever, night sweats, or unintentional weight loss
Common Symptoms
  • • Persistent painful lymphadenopathy (swollen neck/axillary nodes)
  • • Severe bone pain or pathological fractures (Multiple Myeloma)
  • • Recurrent painful vaso-occlusive crises or severe joint hemarthrosis
  • • Splenomegaly and mucosal bleeding
Emergency Symptoms
  • • Neutropenic fever > 100.4°F (38.3°C) during chemotherapy
  • • Spontaneous intracranial or retroperitoneal hemorrhage
  • • Acute chest syndrome in Sickle Cell Anemia
Etiology & Demographics

Causes & Risk Factors

Primary Causes & Etiology

  • Clonal hematopoietic stem cell mutations (JAK2, FLT3, NPM1, BCR-ABL1, TP53)
  • Genetic hemoglobinopathies (Beta-Thalassemia Major, Sickle Cell Disease)
  • Immune-mediated marrow aplasia or platelet autoantibodies
  • Factor VIII / IX genetic deficiency (X-linked Hemophilia A & B)

Who is at Higher Risk?

  • Patients with diagnosed hematological malignancies or inherited blood disorders
  • Individuals requiring bone marrow stem cell transplantation or targeted cellular immunotherapies
Pre-Operative Protocol

Diagnostic Evaluation & Testing

Diagnostic Test Clinical Purpose / What It Shows
High-Resolution 10-Allele HLA-A, B, C, DRB1, DQB1 Tissue Typing & Chimerism Testing Comprehensive bone marrow aspirate cytogenetics, flow cytometry immunophenotyping, and molecular NGS testing
Surgical Techniques

Comprehensive Treatment Options

10/10 HLA-Matched Sibling / Matched Unrelated Donor Allogeneic Stem Cell Infusion

Primary Choice

Advanced targeted cellular therapy, stem cell transplantation, or biologic intervention.

Key Advantages:
Curative potential for previously fatal blood cancers and hemoglobinopathies
Targeted precision immunotherapies sparing healthy tissue
High-dose stem cell rescue capabilities

Myeloablative / Reduced Intensity Conditioning (RIC) Fludarabine-Busulfan Regimen

Complex Cases

Multidisciplinary conditioning chemotherapy or chronic management protocol.

Recommended For:
Relapsed or refractory hematological malignancies
High-risk cytogenetic or molecular profile

Advanced Medical Technologies Available in Partner Hospitals

Autologous & Allogeneic BMT CAR-T Cell Therapy High-Resolution 10-Allele HLA Typing Flow Cytometry CD34+
Clinical Risk Warning

Possible Complications If Untreated

Graft-Versus-Host Disease (GVHD)
Cytokine Release Syndrome (CRS) / ICANS
Febrile neutropenia and opportunistic fungal infections
Post-Operative Milestone

Recovery Timeline, Diet & Lifestyle Care

Recovery Timeline

Procedure / Stage Expected Recovery Duration
HEPA-Filtered BMT Isolation Unit 14 to 21 days
Neutrophil & Platelet Engraftment 21 to 28 days
Outpatient Immunosuppression Taper 3 to 6 months

Recommended Post-Treatment Diet

  • Strict neutropenic clean diet (well-cooked food, no raw fruits/salads)
  • Sterile bottled water
  • High protein nutrition

Essential Lifestyle Changes

  • Wear N95 mask in public and avoid crowds during immunosuppression
  • Take Tacrolimus/Acyclovir at exact 12-hour intervals
  • Daily temperature and blood pressure logging
When to Contact a Doctor Urgently:
Fever > 100.4°F (38°C)
New skin rash or severe watery diarrhea (GVHD warning)
Bleeding or petechiae
Long-Term Health

Prevention & Long-Term Health

Genetic counseling and prenatal screening for Thalassemia & Sickle Cell
Complete vaccination protocol post-BMT
Transparent Benchmark

Global Cost Comparison Matrix

Procedure USA (Avg) India (ISG Network) Turkey (Avg) Thailand (Avg)
Bone marrow transplant (allogeneic — related & MUD) $180,000 $26,000 $45,000 $50,000
Patient Knowledgebase

Frequently Asked Questions

What is the success rate of Bone marrow transplant (allogeneic — related & MUD)?

Cure rates for BMT and CAR-T cell therapy exceed 75-90% in JCI accredited hematology centers of excellence under experienced transplant teams.

Bone marrow transplant (allogeneic — related & MUD)
Bone marrow transplant (allogeneic — related & MUD)
Press Esc or click anywhere outside to close
24/7 International Patient Coordination

Need Help Planning Your Medical Travel?

Connect directly with our patient coordinators for multi-hospital cost comparisons, specialist doctor opinions, and medical visa invitation letters — 100% free with zero facilitation fees.